BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12393546)

  • 1. Mutations in the VHL gene in sporadic apparently congenital polycythemia.
    Pastore YD; Jelinek J; Ang S; Guan Y; Liu E; Jedlickova K; Krishnamurti L; Prchal JT
    Blood; 2003 Feb; 101(4):1591-5. PubMed ID: 12393546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.
    Pastore Y; Jedlickova K; Guan Y; Liu E; Fahner J; Hasle H; Prchal JF; Prchal JT
    Am J Hum Genet; 2003 Aug; 73(2):412-9. PubMed ID: 12844285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry.
    Percy MJ; McMullin MF; Jowitt SN; Potter M; Treacy M; Watson WH; Lappin TR
    Blood; 2003 Aug; 102(3):1097-9. PubMed ID: 12702509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia.
    Ang SO; Chen H; Hirota K; Gordeuk VR; Jelinek J; Guan Y; Liu E; Sergueeva AI; Miasnikova GY; Mole D; Maxwell PH; Stockton DW; Semenza GL; Prchal JT
    Nat Genet; 2002 Dec; 32(4):614-21. PubMed ID: 12415268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors.
    Gordeuk VR; Sergueeva AI; Miasnikova GY; Okhotin D; Voloshin Y; Choyke PL; Butman JA; Jedlickova K; Prchal JT; Polyakova LA
    Blood; 2004 May; 103(10):3924-32. PubMed ID: 14726398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endemic polycythemia in Russia: mutation in the VHL gene.
    Ang SO; Chen H; Gordeuk VR; Sergueeva AI; Polyakova LA; Miasnikova GY; Kralovics R; Stockton DW; Prchal JT
    Blood Cells Mol Dis; 2002; 28(1):57-62. PubMed ID: 11987242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis.
    Cario H; Schwarz K; Jorch N; Kyank U; Petrides PE; Schneider DT; Uhle R; Debatin KM; Kohne E
    Haematologica; 2005 Jan; 90(1):19-24. PubMed ID: 15642664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The homozygous VHL(D126N) missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension.
    Sarangi S; Lanikova L; Kapralova K; Acharya S; Swierczek S; Lipton JM; Wolfe L; Prchal JT
    Pediatr Blood Cancer; 2014 Nov; 61(11):2104-6. PubMed ID: 24729484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W).
    Tomasic NL; Piterkova L; Huff C; Bilic E; Yoon D; Miasnikova GY; Sergueeva AI; Niu X; Nekhai S; Gordeuk V; Prchal JT
    Haematologica; 2013 Apr; 98(4):560-7. PubMed ID: 23403324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital polycythemias/erythrocytoses.
    Gordeuk VR; Stockton DW; Prchal JT
    Haematologica; 2005 Jan; 90(1):109-16. PubMed ID: 15642677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Homozygous Mutation of the Internal Translation Initiation Start Site of VHL is Exclusively Associated with Erythrocytosis: Indications for Distinct Functional Roles of von Hippel-Lindau Tumor Suppressor Isoforms.
    Bartels M; van der Zalm MM; van Oirschot BA; Lee FS; Giles RH; Kruip MJ; Gitz-Francois JJ; Van Solinge WW; Bierings M; van Wijk R
    Hum Mutat; 2015 Nov; 36(11):1039-42. PubMed ID: 26224408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer.
    Lanikova L; Lorenzo F; Yang C; Vankayalapati H; Drachtman R; Divoky V; Prchal JT
    Blood; 2013 May; 121(19):3918-24. PubMed ID: 23538339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a new
    Lenglet M; Robriquet F; Schwarz K; Camps C; Couturier A; Hoogewijs D; Buffet A; Knight SJL; Gad S; Couvé S; Chesnel F; Pacault M; Lindenbaum P; Job S; Dumont S; Besnard T; Cornec M; Dreau H; Pentony M; Kvikstad E; Deveaux S; Burnichon N; Ferlicot S; Vilaine M; Mazzella JM; Airaud F; Garrec C; Heidet L; Irtan S; Mantadakis E; Bouchireb K; Debatin KM; Redon R; Bezieau S; Bressac-de Paillerets B; Teh BT; Girodon F; Randi ML; Putti MC; Bours V; Van Wijk R; Göthert JR; Kattamis A; Janin N; Bento C; Taylor JC; Arlot-Bonnemains Y; Richard S; Gimenez-Roqueplo AP; Cario H; Gardie B
    Blood; 2018 Aug; 132(5):469-483. PubMed ID: 29891534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis.
    Hickey MM; Lam JC; Bezman NA; Rathmell WK; Simon MC
    J Clin Invest; 2007 Dec; 117(12):3879-89. PubMed ID: 17992257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma.
    Wiesener MS; Seyfarth M; Warnecke C; Jürgensen JS; Rosenberger C; Morgan NV; Maher ER; Frei U; Eckardt KU
    Blood; 2002 May; 99(10):3562-5. PubMed ID: 11986208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene.
    Hughson MD; He Z; Liu S; Coleman J; Shingleton WB
    Cancer Genet Cytogenet; 2003 Jun; 143(2):145-53. PubMed ID: 12781449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemia.
    van Rooijen E; Voest EE; Logister I; Korving J; Schwerte T; Schulte-Merker S; Giles RH; van Eeden FJ
    Blood; 2009 Jun; 113(25):6449-60. PubMed ID: 19304954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster.
    Perrotta S; Nobili B; Ferraro M; Migliaccio C; Borriello A; Cucciolla V; Martinelli V; Rossi F; Punzo F; Cirillo P; Parisi G; Zappia V; Rotoli B; Della Ragione F
    Blood; 2006 Jan; 107(2):514-9. PubMed ID: 16210343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.